9 Sep 2024 16:45 to 17:05 Symposium VEXAS Syndrome in 2024 Session 5 Olivier Kosmider First International THEMA Leukemia Symposium 9 Sep 2024 16:45 to 17:05 Share Facebook LinkedIn Bluesky Threads Copy url Audio-visual RSS
Monday 9 September 2024 Amphithéâtre Marguerite de Navarre, Site Marcelin Berthelot Open to all 16:45 - 17:05 Speaker(s) Olivier Kosmider Events Previous Symposium 9 Sep 2024 09:00 to 09:30 Hugues de Thé, Lise Alter & Matthieu Resche-Rigon Opening speech Not recorded Symposium 9 Sep 2024 09:30 to 09:50 Andreas Trumpp Therapy Response and Resistance of AML Stem Cells to Venetoclax Symposium 9 Sep 2024 10:00 to 10:20 Andrew Lane Targetable Leukemia Dependency on Noncanonical PI3Ky Signaling Symposium 9 Sep 2024 10:30 to 10:50 Alexandre Puissant Overcoming Therapy Resistance in Acute Myeloid Leukemia Symposium 9 Sep 2024 11:10 to 11:40 Nina Cabezas Regulation of Hematopoietic Stem Cell Dormancy Symposium 9 Sep 2024 11:40 to 12:00 Lina Benajiba Unmasking Myeloproliferative Neoplasms Transformation Paths Symposium 9 Sep 2024 12:05 to 12:30 Clemens Schmitt AML State-Switched Not recorded Symposium 9 Sep 2024 14:30 to 14:55 Marc Raaijmakers Deconstructing Niche Contributions to Disease Pathogenesis and Drug Resistance in AML Symposium 9 Sep 2024 14:55 to 15:20 Diana Passaro Unveil the Role of the Bone Marrow Vascular Niche in Acute Leukemia Not recorded Symposium 9 Sep 2024 15:20 to 15:40 David Michonneau Lessons from Azithromycin after allo-HSCT: how an antibiotic can promote relapse by disrupting immun… Symposium 9 Sep 2024 16:00 to 16:20 Emmanuel Raffoux Quality of Life Matters: A patient perspective Symposium 9 Sep 2024 16:20 to 16:45 Courtney DiNardo AML Therapy in 2024: increasingly individualized approaches Symposium 9 Sep 2024 16:45 to 17:05 Olivier Kosmider VEXAS Syndrome in 2024 Symposium 9 Sep 2024 17:05 to 17:30 Régis Peffault de Latour Paroxysmal Nocturnal Hemoglobinuria as an Original Non-Malignant Clonal Expansion Modulated by Compl… Symposium 10 Sep 2024 09:00 to 09:25 Lars Velten Tracking Human Hematopoietic Stem Cell Clones in Health and Disease Symposium 10 Sep 2024 09:25 to 09:50 Emmanuelle Clappier Genomic and Clinical Heterogeneity within Adult Acute Lymphoblastic Leukemia Symposium 10 Sep 2024 09:50 to 10:15 Guillaume Andrieu From Metabolic Vulnerabilities to Targeted Therapies in Leukemia Symposium 10 Sep 2024 10:15 to 10:40 Anindita Roy Developmental Origins of Childhood Leukemia: why does it matter? Symposium 10 Sep 2024 11:00 to 11:25 Timothy Ley AML: Lessons from the Genome Not recorded Symposium 10 Sep 2024 11:25 to 11:50 Ruud Delwel Targeting Evil Enhancers and Genes in AML Symposium 10 Sep 2024 11:50 to 12:20 Raphael Itzykson Targeting Cystine Import in AML Symposium 10 Sep 2024 13:50 to 14:15 Keisuke Ito Mitochondrial Contributions to Hematopoietic Homeostasis and the Pathogenesis of Hematological Disor… Symposium 10 Sep 2024 14:15 to 14:40 Bethan Psaila Targeting Microenvironmental Drivers of Blood Malignancies Not recorded Symposium 10 Sep 2024 14:40 to 15:10 Lionel Adès Any Crosstalk in the Treatment of AML and HR-MDS Symposium 10 Sep 2024 15:30 to 15:50 Marie Sebert Clonal Evolution of Genetic Predisposition to Hematological Malignancies Symposium 10 Sep 2024 15:50 to 16:15 Domitille Rérolle PML Unravels New Insights into the Bases of AML Chemotherapy Response Symposium 10 Sep 2024 16:15 to 16:40 Paresh Vyas Clonal Haemopoiesis: stem cell dynamics and stem cell response to inflammation Next See also Hugues de Thé, chair Cellular and Molecular Oncology First International THEMA Leukemia Symposium
Symposium 9 Sep 2024 09:00 to 09:30 Hugues de Thé, Lise Alter & Matthieu Resche-Rigon Opening speech Not recorded
Symposium 9 Sep 2024 09:30 to 09:50 Andreas Trumpp Therapy Response and Resistance of AML Stem Cells to Venetoclax
Symposium 9 Sep 2024 10:00 to 10:20 Andrew Lane Targetable Leukemia Dependency on Noncanonical PI3Ky Signaling
Symposium 9 Sep 2024 10:30 to 10:50 Alexandre Puissant Overcoming Therapy Resistance in Acute Myeloid Leukemia
Symposium 9 Sep 2024 11:40 to 12:00 Lina Benajiba Unmasking Myeloproliferative Neoplasms Transformation Paths
Symposium 9 Sep 2024 14:30 to 14:55 Marc Raaijmakers Deconstructing Niche Contributions to Disease Pathogenesis and Drug Resistance in AML
Symposium 9 Sep 2024 14:55 to 15:20 Diana Passaro Unveil the Role of the Bone Marrow Vascular Niche in Acute Leukemia Not recorded
Symposium 9 Sep 2024 15:20 to 15:40 David Michonneau Lessons from Azithromycin after allo-HSCT: how an antibiotic can promote relapse by disrupting immun…
Symposium 9 Sep 2024 16:20 to 16:45 Courtney DiNardo AML Therapy in 2024: increasingly individualized approaches
Symposium 9 Sep 2024 17:05 to 17:30 Régis Peffault de Latour Paroxysmal Nocturnal Hemoglobinuria as an Original Non-Malignant Clonal Expansion Modulated by Compl…
Symposium 10 Sep 2024 09:00 to 09:25 Lars Velten Tracking Human Hematopoietic Stem Cell Clones in Health and Disease
Symposium 10 Sep 2024 09:25 to 09:50 Emmanuelle Clappier Genomic and Clinical Heterogeneity within Adult Acute Lymphoblastic Leukemia
Symposium 10 Sep 2024 09:50 to 10:15 Guillaume Andrieu From Metabolic Vulnerabilities to Targeted Therapies in Leukemia
Symposium 10 Sep 2024 10:15 to 10:40 Anindita Roy Developmental Origins of Childhood Leukemia: why does it matter?
Symposium 10 Sep 2024 13:50 to 14:15 Keisuke Ito Mitochondrial Contributions to Hematopoietic Homeostasis and the Pathogenesis of Hematological Disor…
Symposium 10 Sep 2024 14:15 to 14:40 Bethan Psaila Targeting Microenvironmental Drivers of Blood Malignancies Not recorded
Symposium 10 Sep 2024 15:30 to 15:50 Marie Sebert Clonal Evolution of Genetic Predisposition to Hematological Malignancies
Symposium 10 Sep 2024 15:50 to 16:15 Domitille Rérolle PML Unravels New Insights into the Bases of AML Chemotherapy Response
Symposium 10 Sep 2024 16:15 to 16:40 Paresh Vyas Clonal Haemopoiesis: stem cell dynamics and stem cell response to inflammation